Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | 7280-77-5;CYCLO(-LEU-PHE);cyclo(L-Phe-L-Leu);Cyclo(L-leucyl-L-phenylalanyl);Cyclo(Leu-Phe);Cyclo(-L-Leu-L-Phe);Cyclo(leucyl-phenylalanyl);cyclo(L-Leu-L-Phe);cyclo(L-phenylalanyl-L-leucyl);L-Phenylalanyl-L-leucine diketopiperazine;(3S,6S)-3-benzyl-6-(2-methylpropyl)piperazine-2,5-dione;(3S,6S)-3-benzyl-6-isobutylpiperazine-2,5-dione;CHEBI:71608;2,5-Piperazinedione, 3-(2-methylpropyl)-6-(phenylmethyl)-, (3S,6S)-;(3S,6S)-3-(2-Methylpropyl)-6-(phenylmethyl)-2,5-piperazinedione;MFCD00672388;cyclo(-leu-phe), AldrichCPR;CHEMBL189999;SCHEMBL2864427;2,5-Piperazinedione, 3-benzyl-6-isobutyl-, (3S,6S)-;Cyclo-(l-leucyl-l-phenylalanyl);DTXSID20993602;HY-P4617;2,5-Piperazinedione, 3-(2-methylpropyl)-6-(phenylmethyl)-, (3S-cis)-;AKOS027250806;FC49434;AS-87876;DB-230139;3-Benzyl-6-isobutyl-2,5-piperazinedione #;CS-0655411;C20519;Q27139751;3-Benzyl-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol;cFL; |
M.F/Formula | C15H20N2O2 |
M.W/Mr. | 260.33 |
InChI | InChI=1S/C15H20N2O2/c1-10(2)8-12-14(18)17-13(15(19)16-12)9-11-6-4-3-5-7-11/h3-7,10,12-13H,8-9H2,1-2H3,(H,16,19)(H,17,18)/t12-,13-/m0/s1 |
InChI Key | QPDMOMIYLJMOQJ-STQMWFEESA-N |
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.